Literature DB >> 6424441

New concepts about the pathogenesis of atherosclerosis in diabetes mellitus.

J A Colwell, P D Winocour, M Lopes-Virella, P V Halushka.   

Abstract

New concepts about the pathogenesis of atherosclerosis in diabetes mellitus are presented. Emphasis is given to alterations of endothelial function, as indicated by von Willebrand factor activity, prostacyclin release, and fibrinolytic activity in diabetes mellitus. Previous work on platelet aggregation and arachidonic acid metabolism is updated and recent findings are emphasized. The atherogenic mix of elevated low-density lipoprotein cholesterol and low high-density lipoprotein cholesterol levels in uncontrolled diabetes mellitus is noted. The lipid hypothesis is extended by consideration of very low-density lipoprotein and intermediate-density lipoprotein metabolism in diabetes. Lipoprotein-cell interactions that may contribute to atherosclerosis are reviewed and suggestions are made for future research in order to clarify the pathogenesis of atherosclerosis in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6424441     DOI: 10.1016/0002-9343(83)90256-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

Review 1.  The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.

Authors:  S C Bain; P M Dodson
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

2.  Non-insulin dependent diabetes and ischaemic heart disease.

Authors:  J T Salonen
Journal:  BMJ       Date:  1989-04-22

Review 3.  Antiplatelet agents and diabetic vascular disease.

Authors:  J A Colwell
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

4.  Effect of alpha 2-adrenoceptor antagonist on platelet activation during insulin-induced hypoglycaemia in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  H Takeda; H Kishikawa; M Shinohara; T Miyata; K Suzaki; H Fukushima; K Ichinose; M Shichiri
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

Review 5.  Cardiovascular disease in diabetes: where does glucose fit in?

Authors:  Jane E B Reusch; Cecilia C Low Wang
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

6.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

Authors:  A Fontbonne; E Eschwège; F Cambien; J L Richard; P Ducimetière; N Thibult; J M Warnet; J R Claude; G E Rosselin
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

Review 7.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

8.  Increased intracellular calcium mobilization in platelets from patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  H Ishii; F Umeda; T Hashimoto; H Nawata
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

9.  Thrombin-induced platelet aggregation, phosphoinositide metabolism and protein phosphorylation in NIDDM patients treated by diet, sulphonylurea or insulin.

Authors:  T Ishizuka; O Taniguchi; M Yamamoto; K Kajita; T Nagashima; N Takeda; H Inouye; K Yasuda; K Miura
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

10.  Relationship between vascular adrenergic receptors and prostaglandin biosyntheses in canine diabetic coronary arteries.

Authors:  M Z Koltai; P Rösen; P Hadházy; G Ballagi-Pordány; A Köszeghy; G Pogátsa
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.